Cargando…

Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study

BACKGROUND: Erythropoietic protoporphyria (EPP) is an ultra-rare genetic disorder (prevalence 1:150`000) characterized by instant painful phototoxic burn reactions in skin exposed to visible light. Afamelanotide is the first clinically tested therapy effectively increasing the time EPP patients can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barman-Aksözen, Jasmin, Nydegger, Michèle, Schneider-Yin, Xiaoye, Minder, Anna-Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437008/ https://www.ncbi.nlm.nih.gov/pubmed/32811524 http://dx.doi.org/10.1186/s13023-020-01505-6

Ejemplares similares

Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study
por: Minder, Anna-Elisabeth, et al.
Publicado: (2021)

Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
por: Minder, Anna-Elisabeth, et al.
Publicado: (2023)

Advances in the management of erythropoietic protoporphyria – role of afamelanotide
por: Lane, Ashley M, et al.
Publicado: (2016)

Current trials in erythropoietic protoporphyria: are placebo controls ethical?
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2023)

Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2017)

Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria
por: Halloy, François, et al.
Publicado: (2020)

Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility Study
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2023)

Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal
por: Minder, Elisabeth I, et al.
Publicado: (2010)

Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients
por: Granata, Francesca, et al.
Publicado: (2022)

Protection from phototoxic injury during laparoscopic surgery in patients with erythropoietic protoporphyria
por: Pielaciński, Konrad, et al.
Publicado: (2022)

Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009)

Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022)

How I treat erythropoietic protoporphyria and X-linked protoporphyria
por: Leaf, Rebecca Karp, et al.
Publicado: (2023)

The role of ClpX in erythropoietic protoporphyria
por: Whitman, Jared C., et al.
Publicado: (2018)

UK experience of liver transplantation for erythropoietic protoporphyria
por: Dowman, Joanna K., et al.
Publicado: (2011)

Laparoscopic Cholecystectomy in a Patient with Erythropoietic Protoporphyria
por: Roe, Thomas, et al.
Publicado: (2010)

Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria
por: Dickey, Amy K., et al.
Publicado: (2020)

Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
por: Di Pierro, Elena, et al.
Publicado: (2022)

A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
por: Balwani, Manisha, et al.
Publicado: (2022)

An Unusual Case of Erythropoietic Protoporphyria Mimicking Lipoid Proteinosis
por: Kaur, Sarabjit, et al.
Publicado: (2019)

Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy
por: Yoshida, Akihiro, et al.
Publicado: (2018)

Erythropoietic protoporphyria: Delayed presentation with decompensated liver disease
por: Sarda, Radhika, et al.
Publicado: (2020)

Erythropoietic protoporphyria: case reports for clinical and therapeutic hints
por: Tumminelli, Cristina, et al.
Publicado: (2023)

Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X‐linked protoporphyria
por: Naik, Hetanshi, et al.
Publicado: (2019)

Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
por: Poli, Antoine, et al.
Publicado: (2023)

Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria
por: Teramura, Takashi, et al.
Publicado: (2017)

The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria
por: Wang, Pengcheng, et al.
Publicado: (2019)

Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
por: Biolcati, G., et al.
Publicado: (2021)

Characterization of a novel pathogenic variant in the FECH gene associated with erythropoietic protoporphyria
por: Kieke, Michele C., et al.
Publicado: (2019)

Erythropoietic Protoporphyria Masquerading as Angioedema in a 4-Year-Old Female
por: Wang, Helen C, et al.
Publicado: (2006)

Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria
por: Park, Pyoung-Jae, et al.
Publicado: (2012)

Bovine congenital erythropoietic protoporphyria in a crossbred limousin heifer in Ireland
por: McAloon, Conor G., et al.
Publicado: (2015)

Delayed photosensitivity in a child with erythropoietic protoporphyria : a case report
por: Kiberd, James, et al.
Publicado: (2018)

Diagnosis of erythropoietic protoporphyria with severe liver injury: A case report
por: Liu, Hui-Min, et al.
Publicado: (2019)

Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
por: Biolcati, G., et al.
Publicado: (2021)

The 6-year follow-up of a Japanese patient with silent erythropoietic protoporphyria
por: Mizawa, Megumi, et al.
Publicado: (2017)

Microvascular Hepatic Artery Anastomosis in Living Donor Liver Transplantation for Erythropoietic Protoporphyria
por: Yamashita, Shuji, et al.
Publicado: (2020)

Erythropoietic Protoporphyria: You May Not Have Seen It, but It May Have Seen You
por: Pastore, Larissa M, et al.
Publicado: (2022)

In vitro Assessment of Solar Filters for Erythropoietic Protoporphyria in the Action Spectrum of Protoporphyrin IX
por: Sernicola, Alvise, et al.
Publicado: (2021)

Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria
por: Mathias, Susan D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rog4stpshqfe7iid1f7l6t861m